Brian J. Davis

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.

D. Tindall, C. Magi-Galluzzi, C. Reddy, 2016, The Lancet. Oncology.

The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.

B. Davis, R. Karnes, J. Tilburt, 2012, Mayo Clinic proceedings.

Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.

J. Felmlee, I. Frank, A. Kawashima, 2013, Urology.

Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis

B. Stish, Ahmed M. Mahmoud, Geoff B. Johnson, 2023, The Prostate.

11C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities

Sean S. Park, V. Lowe, W. Harmsen, 2019, Advances in radiation oncology.

Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.

B. Stish, T. Pisansky, K. Olivier, 2017, International journal of radiation oncology, biology, physics.

Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.

William P. Parker, Sean S. Park, V. Lowe, 2017, European urology.